Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 29 September 2009
Vol. 2, Issue 90, p. ra59
[DOI: 10.1126/scisignal.2000300]


Editor's Summary

Apoptosis, With or Without Hippo
The Hippo signaling pathway, named after the kinase Hippo, limits organ size without affecting patterning, and the components of this pathway are conserved from Drosophila to mammals. Drosophila RASSF (Ras association domain family) not only inhibits Hippo signaling and thus counters Hippo-mediated apoptosis, but also exhibits tumor suppressor function. Of the 10 mammalian RASSF isoforms, the best-characterized isoform, RASSF1A, activates the mammalian homologs of Hippo (the MST kinases), which contrasts with the role of dRASSF. Ikeda et al. show that RASSF6 represents another twist in the RASSF protein family. RASSF6 and MST2 are mutual inhibitors: Activation of MST2 disrupted binding of RASSF6 to MST2, enabling MST2 to induce apoptosis through a process dependent on the Hippo pathway and allowing RASSF6 to mediate apoptosis through a Hippo-independent pathway. These results suggest that mammalian RASSF isoforms may have divergent functions and may link the Hippo pathway to other signal transduction cascades.

Citation: M. Ikeda, A. Kawata, M. Nishikawa, Y. Tateishi, M. Yamaguchi, K. Nakagawa, S. Hirabayashi, Y. Bao, S. Hidaka, Y. Hirata, Y. Hata, Hippo Pathway–Dependent and –Independent Roles of RASSF6. Sci. Signal. 2, ra59 (2009).

Read the Full Text

Screening with a Novel Cell-Based Assay for TAZ Activators Identifies a Compound That Enhances Myogenesis in C2C12 Cells and Facilitates Muscle Repair in a Muscle Injury Model.
Z. Yang, K. Nakagawa, A. Sarkar, J. Maruyama, H. Iwasa, Y. Bao, M. Ishigami-Yuasa, S. Ito, H. Kagechika, S. Hata, et al. (2014)
Mol. Cell. Biol. 34, 1607-1621
   Abstract »    Full Text »    PDF »
Protein Interaction Network of the Mammalian Hippo Pathway Reveals Mechanisms of Kinase-Phosphatase Interactions.
A. L. Couzens, J. D. R. Knight, M. J. Kean, G. Teo, A. Weiss, W. H. Dunham, Z.-Y. Lin, R. D. Bagshaw, F. Sicheri, T. Pawson, et al. (2013)
Science Signaling 6, rs15
   Abstract »    Full Text »    PDF »
The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and the Cell Cycle via MDM2 Protein and p53 Protein.
H. Iwasa, T. Kudo, S. Maimaiti, M. Ikeda, J. Maruyama, K. Nakagawa, and Y. Hata (2013)
J. Biol. Chem. 288, 30320-30329
   Abstract »    Full Text »    PDF »
The Hippo pathway: regulators and regulations.
F.-X. Yu and K.-L. Guan (2013)
Genes & Dev. 27, 355-371
   Abstract »    Full Text »    PDF »
Expression of RASSF6 in kidney and the implication of RASSF6 and the Hippo pathway in the sorbitol-induced apoptosis in renal proximal tubular epithelial cells.
K. Withanage, K. Nakagawa, M. Ikeda, H. Kurihara, T. Kudo, Z. Yang, A. Sakane, T. Sasaki, and Y. Hata (2012)
J. Biochem. 152, 111-119
   Abstract »    Full Text »    PDF »
The RASSF3 Candidate Tumor Suppressor Induces Apoptosis and G1-S Cell-Cycle Arrest via p53.
T. Kudo, M. Ikeda, M. Nishikawa, Z. Yang, K. Ohno, K. Nakagawa, and Y. Hata (2012)
Cancer Res. 72, 2901-2911
   Abstract »    Full Text »    PDF »
Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation.
K. Zhang, E. Rodriguez-Aznar, N. Yabuta, R. J. Owen, J. M. Mingot, H. Nojima, M. A. Nieto, and G. D. Longmore (2012)
EMBO J. 31, 29-43
   Abstract »    Full Text »    PDF »
A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription.
Y. Bao, K. Nakagawa, Z. Yang, M. Ikeda, K. Withanage, M. Ishigami-Yuasa, Y. Okuno, S. Hata, H. Nishina, and Y. Hata (2011)
J. Biochem. 150, 199-208
   Abstract »    Full Text »    PDF »
The growing role of the Hippo-NDR kinase signalling in neuronal development and disease.
K. Emoto (2011)
J. Biochem. 150, 133-141
   Abstract »    Full Text »    PDF »
Mammalian Hippo pathway: from development to cancer and beyond.
Y. Bao, Y. Hata, M. Ikeda, and K. Withanage (2011)
J. Biochem. 149, 361-379
   Abstract »    Full Text »    PDF »
The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2.
C. Guo, X. Zhang, and G. P. Pfeifer (2011)
J. Biol. Chem. 286, 6253-6261
   Abstract »    Full Text »    PDF »
Hippo signaling: growth control and beyond.
G. Halder and R. L. Johnson (2011)
Development 138, 9-22
   Abstract »    Full Text »    PDF »
Tumor Suppressor Ras Association Domain Family 5 (RASSF5/NORE1) Mediates Death Receptor Ligand-induced Apoptosis.
J. Park, S. I. Kang, S.-Y. Lee, X. F. Zhang, M. S. Kim, L. F. Beers, D.-S. Lim, J. Avruch, H.-S. Kim, and S. B. Lee (2010)
J. Biol. Chem. 285, 35029-35038
   Abstract »    Full Text »    PDF »
Mammalian Ste20-like Kinase (Mst2) Indirectly Supports Raf-1/ERK Pathway Activity via Maintenance of Protein Phosphatase-2A Catalytic Subunit Levels and Consequent Suppression of Inhibitory Raf-1 Phosphorylation.
G. K. Kilili and J. M. Kyriakis (2010)
J. Biol. Chem. 285, 15076-15087
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882